Summary
Alan Robertson is a biotechnology executive and entrepreneur with over a decade of leadership building companies to tackle tough therapeutic challenges, currently serving as CEO and Managing Director of Alsonex and Managing Director of Canthera Discovery. With a PhD in Chemistry from the University of Glasgow and a track record spanning CEO roles, board chairs and non-executive directorships, he blends deep scientific expertise in biomarkers, oncology, vaccines and medical devices with hands-on venture-building experience. He led Pharmaxis as CEO for 13 years and now focuses on translational programs including a novel treatment for motor neuron disease and a device-based cancer therapy. Comfortable moving between lab science and boardroom strategy, he also advises emerging biotechs and occasionally writes code of “highly variable quality” on GitHub, hinting at a pragmatic, hands-on approach to problem solving.
10 years of coding experience
25 years of employment as a software developer
Doctor of Philosophy (PhD) Chemistry, Doctor of Philosophy (PhD) Chemistry at University of Glasgow